5L
VRTX icon

55I LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

55I LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$859K Buy
2,965
+2,255
+318% +$649K 0.02% 287
2022
Q2 		$200K Buy
+710
New +$190K 0.01% 534

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

55I LLC's VRTX Position: Q3 2022 in Review

55I LLC increased its Vertex Pharmaceuticals (VRTX) stake by 318% in Q3 2022, buying an estimated $649K and bringing the position to 2,965 shares worth $859K. The position accounts for 0.02% of the portfolio, ranked #287.

55I LLC first reported a position in VRTX in Q2 2022 and has held it in 2 quarters since. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • 55I LLC held 2,965 shares of Vertex Pharmaceuticals worth $859K as of Q3 2022.
  • 55I LLC bought 2,255 Vertex Pharmaceuticals shares in Q3 2022, an estimated $649K.
  • Vertex Pharmaceuticals made up 0.02% of 55I LLC's portfolio in Q3 2022, its #287 holding.
  • 55I LLC first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 2 quarters since.
  • 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.